• Je něco špatně v tomto záznamu ?

A review of a newly established ECMO program in a university affiliated cardiac center

J. Belohlávek, V. Rohn, J. Tosovsky, J. Kunstyr, M. Semrád, J. Horák, M. Lips, F. Mlejnsky, I. Vykydal, M. Balík, M. Strítesky, V. Mrázek, A. Klein, A. Linhart, J. Lindner,

. 2011 ; 52 (3) : 445-51.

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027530

Extracorporeal membrane oxygenation (ECMO) is an established rescue treatment option for severe respiratory and cardiac failure in infants and neonates and has recently become widely utilised in adults. ECMO support can be initiated rapidly in an emergency setting both by percutanous implantation and surgically; it allows transportation of patients in cardio-pulmonary collapse and bridging of critically ill patients to be recovered, other support measures or transplantation. The aim of this study was to report authors' initial experience after starting an ECMO program in a university-based cardiac center. The institutionally approved ECMO team bears responsibility for adjudication regarding indication and implementation of ECMO in all patients. Since the establishment of the ECMO team in October 2007, one elective and nine urgent patients in deep cardiogenic and/or ventilatory collapse were treated by ECMO support up to December 2008. Three patients suffered severe acute right heart dysfunction, two patients suffered postcardiotomy refractory cardiogenic shock, two patients had a cardiogenic shock due to postinfarction interventricular septal rupture, two patients experienced severe respiratory failure and one had elective ECMO implantation as a back-up support during high-risk percutaneous coronary intervention. Veno-arterial ECMO was used in eight cases and veno-venous in two cases of isolated respiratory failure. In nine patients, ECMO circuit was instituted by peripheral cannulation, in eight out of nine cases by percutaneous puncture. On one occasion central surgical cannulation was used. In urgent patients, immediate hemodynamic and oxygenation improvement was observed. Average support duration was 6.8 days (range 1-16 days). Five (50 %) patients were successfully weaned from ECMO and survived to hospital discharge. The illness severity in urgent patients defined by SOFA score ranged from 10 to 17, patients dying while on ECMO had higher SOFA scores (14.8±1.6 vs. 10.8±1.5; P=0.0065). Complications included mainly bleeding. ECMO support allows treatment of severely ill patients in imminent cardiovascular and/or ventilatory collapse. Therefore, establishment of an ECMO program in university affiliated cardiac center is fully justified. A multidisciplinary approach is essential. Despite adequate training and education of ECMO team members, this highly invasive therapeutic modality bears an inherent risk of complications.

000      
00000naa a2200000 a 4500
001      
bmc12027530
003      
CZ-PrNML
005      
20121216200309.0
007      
ta
008      
120817s2011 it f 000 0#eng||
009      
AR
035    __
$a (PubMed)21577197
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Bělohlávek, Jan, $d 1971- $7 xx0077681 $u 2nd Department of Internal Medicine, Cardiology and Angiology, General Teaching Hospital, Charles University, Prague, Czech Republic. jbelo@vfn.cz
245    12
$a A review of a newly established ECMO program in a university affiliated cardiac center / $c J. Belohlávek, V. Rohn, J. Tosovsky, J. Kunstyr, M. Semrád, J. Horák, M. Lips, F. Mlejnsky, I. Vykydal, M. Balík, M. Strítesky, V. Mrázek, A. Klein, A. Linhart, J. Lindner,
520    9_
$a Extracorporeal membrane oxygenation (ECMO) is an established rescue treatment option for severe respiratory and cardiac failure in infants and neonates and has recently become widely utilised in adults. ECMO support can be initiated rapidly in an emergency setting both by percutanous implantation and surgically; it allows transportation of patients in cardio-pulmonary collapse and bridging of critically ill patients to be recovered, other support measures or transplantation. The aim of this study was to report authors' initial experience after starting an ECMO program in a university-based cardiac center. The institutionally approved ECMO team bears responsibility for adjudication regarding indication and implementation of ECMO in all patients. Since the establishment of the ECMO team in October 2007, one elective and nine urgent patients in deep cardiogenic and/or ventilatory collapse were treated by ECMO support up to December 2008. Three patients suffered severe acute right heart dysfunction, two patients suffered postcardiotomy refractory cardiogenic shock, two patients had a cardiogenic shock due to postinfarction interventricular septal rupture, two patients experienced severe respiratory failure and one had elective ECMO implantation as a back-up support during high-risk percutaneous coronary intervention. Veno-arterial ECMO was used in eight cases and veno-venous in two cases of isolated respiratory failure. In nine patients, ECMO circuit was instituted by peripheral cannulation, in eight out of nine cases by percutaneous puncture. On one occasion central surgical cannulation was used. In urgent patients, immediate hemodynamic and oxygenation improvement was observed. Average support duration was 6.8 days (range 1-16 days). Five (50 %) patients were successfully weaned from ECMO and survived to hospital discharge. The illness severity in urgent patients defined by SOFA score ranged from 10 to 17, patients dying while on ECMO had higher SOFA scores (14.8±1.6 vs. 10.8±1.5; P=0.0065). Complications included mainly bleeding. ECMO support allows treatment of severely ill patients in imminent cardiovascular and/or ventilatory collapse. Therefore, establishment of an ECMO program in university affiliated cardiac center is fully justified. A multidisciplinary approach is essential. Despite adequate training and education of ECMO team members, this highly invasive therapeutic modality bears an inherent risk of complications.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kritický stav $7 D016638
650    _2
$a mimotělní membránová oxygenace $x škodlivé účinky $x mortalita $7 D015199
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nemoci srdce $x etiologie $x mortalita $x patofyziologie $x terapie $7 D006331
650    _2
$a mortalita v nemocnicích $7 D017052
650    _2
$a nemocnice fakultní $7 D006784
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a týmová péče o pacienty $7 D010348
650    _2
$a hodnocení programu $7 D015397
650    _2
$a respirační insuficience $x etiologie $x mortalita $x patofyziologie $x terapie $7 D012131
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rohn, Vilém, $d 1960- $7 xx0054482
700    1_
$a Tošovský, Jan, $d 1946- $7 xx0044325
700    1_
$a Kunstýř, Jan $7 xx0083634
700    1_
$a Semrád, Michal $7 xx0092194
700    1_
$a Horák, Jan, $d 1953- $7 jx20040720041
700    1#
$a Lipš, Michal. $7 xx0232731
700    1#
$a Mlejnský, František. $7 _AN029069
700    1#
$a Vykydal, Igor. $7 _AN027076
700    1_
$a Balík, Martin $7 xx0075661
700    1_
$a Stříteský, Martin $7 xx0106193
700    1_
$a Mrázek, Vratislav, $d 1965- $7 xx0060129
700    1_
$a Klein, Andrew
700    1_
$a Linhart, Aleš, $d 1964- $7 mzk2003188958
700    1_
$a Lindner, Jaroslav, $d 1957- $7 mzk2005269705
773    0_
$w MED00002572 $t The Journal of cardiovascular surgery $x 0021-9509 $g Roč. 52, č. 3 (2011), s. 445-51
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21577197 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121216200411 $b ABA008
999    __
$a ok $b bmc $g 949572 $s 784876
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 52 $c 3 $d 445-51 $i 0021-9509 $m Journal of cardiovascular surgery $n J Cardiovasc Surg (Torino) $x MED00002572
LZP    __
$a Pubmed-20120817/11/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...